The Effect of Renal Dysfunction on Circulating Sclerostin Level in Patients with Type 2 Diabetes
El sebaie, M., arafat, M., fawzy, M., salem, I. (2021). The Effect of Renal Dysfunction on Circulating Sclerostin Level in Patients with Type 2 Diabetes. EKB Journal Management System, 27(1), 58-69. doi: 10.21608/zumj.2020.16472.1477
Mahmoud hamdy El sebaie; mohamed abbas arafat; mohamed samy fawzy; ibrahim mohamed salem. "The Effect of Renal Dysfunction on Circulating Sclerostin Level in Patients with Type 2 Diabetes". EKB Journal Management System, 27, 1, 2021, 58-69. doi: 10.21608/zumj.2020.16472.1477
El sebaie, M., arafat, M., fawzy, M., salem, I. (2021). 'The Effect of Renal Dysfunction on Circulating Sclerostin Level in Patients with Type 2 Diabetes', EKB Journal Management System, 27(1), pp. 58-69. doi: 10.21608/zumj.2020.16472.1477
El sebaie, M., arafat, M., fawzy, M., salem, I. The Effect of Renal Dysfunction on Circulating Sclerostin Level in Patients with Type 2 Diabetes. EKB Journal Management System, 2021; 27(1): 58-69. doi: 10.21608/zumj.2020.16472.1477

The Effect of Renal Dysfunction on Circulating Sclerostin Level in Patients with Type 2 Diabetes

Zagazig University Medical Journal
Article 7, Volume 27, Issue 1, January 2021, Page 58-69  XML PDF (1.44 MB)
Document Type: Original Article
DOI: 10.21608/zumj.2020.16472.1477
View on SCiNiTO View on SCiNiTO
Authors
Mahmoud hamdy El sebaie email 1; mohamed abbas arafat2; mohamed samy fawzy3; ibrahim mohamed salem2
1Internal Medecine,faculty of Medecine,Ain shams university,el menoufia,Eygpt
2Internal Medicine Department, Faculty of Medicine, Zagazig University, Sharkia Egypt
3Biochemistry Department, Faculty of Medicine, Zagazig University, Sharkia Egypt
Abstract
Background and aim:
Sclerostin, a soluble canonical Wingless integration site signaling inhibitor, is formed by osteocytes and is vital for bone physiology. This work aimed to appraise the role of sclerostin level in early detection of renal osteodystrophy in patients with type 2 diabetes mellitus (T2DM).
Method:
This cross sectional study was done on 75 diabetic patients with different stages of chronic kidney disease (CKD) in the Internal Medicine department, Zagazig University hospital.The patients are classified into 3 groups according to glomerular filtration rate(GFR),group 1(stage 1,2 CKD),group 2(stage 3 CKD),group 3(stage 4,5 CKD). The patients underwent history taking, examination and laboratory studies including routine investigations and assessment of serum sclerostin.
Results:
The mean age of the patients was 51.07 ± 4.40 years. Males represented 61.3% of them. Mean Sclerostin of them was 5.42 ± 4.53 ng/ml. There are significant differences between groups with different CKD stages regarding sclerostin, hemoglobin, serum creatinine, blood urea, eGFR, phosphorus and parathyroid hormone. There is significant positive correlation between serum sclerostin and all of serum creatinine, blood urea, phosphorus and parathyroid hormone. There is significant negative correlation between it and eGFR. On multivariate regression analysis, it was found that age, serum creatinine, blood urea, eGFR and albumin/creatinine ratio (ACR) significantly associated with serum level.
Conclusion:
Sclerostin level is negatively correlated with eGFR in diabetic patients with impaired renal function. Serum sclerostin levels increase in diabetic patients starting from CKD-G3 stage. Age, serum creatinine, blood urea, eGFR and albumin/creatinine ratio (ACR) significantly associated with its level.
Keywords
Chronic Kidney Disease; diabetes; sclerostin
Statistics
Article View: 331
PDF Download: 273